ATOS logoATOS
Atossa Therapeutics Inc

64,220
Loading...
Loading...
News
all
press releases
Atos shares climb 4% after reporting stronger half-year liquidity position
investing.com·2mo ago
News Placeholder
More News
News Placeholder
BofA assesses the impact of foreign tax in budget bill on European software names
Investing.com - European software companies stand to be hit by a section of a massive Republican budget bill which would tax foreign investors in the United States.
investing.com·3mo ago
News Placeholder
Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
Zacks·4mo ago
News Placeholder
Atos to launch reverse stock split on March 25 to stabilize shares
investing.com·7mo ago
News Placeholder
Atos surges 20% after reporting improved commercial activity post-restructuring
investing.com·7mo ago
News Placeholder
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women PR Newswire...
PR Newswire·11mo ago
News Placeholder
Atossa Therapeutics: A Promising Buy in Oncology with Strong Financials and Upcoming Trial Milestones
Atossa Therapeutics (ATOS Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCart...
TipRanks Financial Blog·1y ago
News Placeholder
Atossa Therapeutics: A Promising Buy Amid Anticipated Clinical Breakthroughs
Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on Atossa Therapeutics (ATOS Research Report), retaining the price target of $6.0...
TipRanks Financial Blog·1y ago
News Placeholder
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response PR Newswire...
PR Newswire·1y ago
News Placeholder
Atossa Therapeutics Inc (ATOS) Year-End Earnings: A Comprehensive Analysis
Atossa Therapeutics Inc (ATOS) Reports Increased Operating Expenses and Advances in Clinical TrialsRelated Stocks: ATOS...
GuruFocus·1y ago

Latest ATOS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.